RESEARCH TRIANGLE PARK, N.C., March 2 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) is prepared with ample supplies of the influenza antiviral medication ...
RELENZA (Zanamivir) 5mg/blister oral inhalation from GlaxoSmithKline The FDA and GlaxoSmithKline have notified healthcare professionals of a report of the death of a patient with influenza who ...
RESEARCH TRIANGLE PARK, N.C., Dec. 19 /PRNewswire/ -- GlaxoSmithKline (GSK) is prepared to respond to public health needs for RELENZA(R) (zanamivir) Inhalation Powder this flu season following a ...
GlaxoSmithKline is alerting healthcare professionals about the dangers of reconstituting Relenza (zanamivir) Inhalation Powder into a liquid and using it in a nebulizer or mechanical ventilator. The ...
October 10, 2009 — The US Food and Drug Administration (FDA) and GlaxoSmithKline are reporting the death of a person with influenza after receiving zanamivir inhalation powder (Relenza) that had been ...
As things stand, if an avian flu pandemic breaks out before a vaccine has been developed, the first line of defense is Roche's much-ballyhooed antiviral drug, Tamiflu. As a second choice, doctors will ...
WASHINGTON (Reuters) - The pandemic of H1N1 swine flu has been a bonus for GlaxoSmithKline, which makes the inhaled flu drug, a vaccine and special antiviral masks, the company said on Wednesday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results